Hemoglobinopathy or Hemoglobinopathies is the medical term for a group of blood disorders and diseases that affect red blood cells. It can be a kind of genetic defect that results in abnormal structure of one of the globin chains of the hemoglobin molecule. Increasing cases of hemoglobinopathies, especially in regions such as Southeast Asia and Africa, is one of the major growth drivers. Market Analysis and Insights: Global Hemoglobinopathies Market The global Hemoglobinopathies market size is projected to reach US$ 384.7 million by 2027, from US$ 274.5 million in 2020, at a CAGR of 4.5% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Hemoglobinopathies market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Hemoglobinopathies market in terms of revenue. On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Hemoglobinopathies market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Hemoglobinopathies market. Global Hemoglobinopathies Scope and Market Size Hemoglobinopathies market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Hemoglobinopathies market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027. Segment by Type Blood Transfusion Iron Chelation Therapy Bone Marrow Transplant Others Segment by Application Blood Testing Genetic Testing Pre-Implantation Genetic Diagnosis (PGD) Others By Region North America U.S. Canada Europe Germany France U.K. Italy Russia Nordic Rest of Europe Asia-Pacific China Japan South Korea Southeast Asia India Australia Rest of Asia Latin America Mexico Brazil Rest of Latin America Middle East & Africa Turkey Saudi Arabia UAE Rest of MEA By Company Gamida Cell Alnylam Pharmaceuticals Sanofi Sangamo Therapeutics Inc. Global Blood Therapeutics Bluebird Bio Emmaus Life Sciences Inc. Prolong Pharmaceuticals Celgene Corporation
1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Hemoglobinopathies Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Blood Transfusion 1.2.3 Iron Chelation Therapy 1.2.4 Bone Marrow Transplant 1.2.5 Others 1.3 Market by Application 1.3.1 Global Hemoglobinopathies Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Blood Tes
